The benefits of chemoprevention include a significant reduction in the incidence of certain cancers. However, it's important to weigh these benefits against potential risks:
Tamoxifen: Can increase the risks of uterine cancer and thromboembolic events. Raloxifene: Generally has a more favorable safety profile compared to tamoxifen but may still pose a risk of thromboembolic events. Oral Contraceptives: May have side effects such as an increased risk of thromboembolic and cardiovascular events.
